Overview
SARS-inhibitor 1, available in a 1 mg dosage, is designed to address the critical need for effective solutions against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the COVID-19 pandemic. As research efforts intensify to find SARS inhibitors, this product stands out by specifically targeting the interaction between the virus and host cells, as well as inhibiting virus replication and enzyme activity, particularly affecting the 2-O-methyltransferase enzyme crucial for viral propagation.
Key Features
- Targets SARS-CoV-2 enzyme activity
- Affects virus-host cell interaction
- 1 mg concentration for precise applications
- Supports ongoing COVID-19 research
Specifications
| Product Name | SARS-inhibitor 1 |
| Concentration | 1 mg |
| Category | Peptides |
FAQ
What is SARS-inhibitor 1 used for?
SARS-inhibitor 1 is utilized in research to study its effects on SARS-CoV-2, focusing on inhibiting the enzyme activity of the virus and its ability to replicate.
How does SARS-inhibitor 1 work?
This inhibitor specifically targets the 2-O-methyltransferase enzyme in SARS-CoV-2, which is vital for viral replication and interaction with host cells.
Who should consider using SARS-inhibitor 1?
This product is ideal for researchers and laboratories involved in virology and COVID-19 research, looking for effective ways to study and mitigate the virus’s impact.
For researchers seeking effective solutions in combating SARS-CoV-2, our SARS-inhibitor 1 is now available for purchase. Enhance your study of virus-host interactions and contribute to vital research efforts by including this essential inhibitor in your toolkit. Interested in exploring more peptide options? Check out our extensive peptides catalog for a variety of related products.




Reviews
There are no reviews yet.